Explore

Study Reveals Widespread Breast Cancer-Linked Chemicals in U.S. Consumer Products

Study Reveals Widespread Breast Cancer-Linked Chemicals in U.S. Consumer Products

A new study led by the Silent Spring Institute in Massachusetts has found that 920 chemicals previously linked to breast cancer are widely present in U.S. consumer products. These chemicals were identified in various items, including paint, personal-care products, hair dyes, food, drinking water, pesticides, building materials, and pharmaceuticals. The research, published in the journal Environmental Health Perspectives, built upon earlier work by the same team that identified these 920 chemicals based on their ability to cause mammary tumors in rodents, increase estrogen or progesterone production, activate estrogen receptors, or damage DNA. The study utilized U.S. government data on chemical production, product uses, industrial releases, air emissions, drinking-water occurrence, and population exposure estimates. It revealed that over two billion pounds of these chemicals were emitted into the air in 2020, and nearly 82 million pounds were released or transferred off-site by large facilities in 2024. Man...

Study Reveals Ubiquitous Presence of Breast Cancer-Linked Chemicals in U.S. Consumer Products

Study Reveals Ubiquitous Presence of Breast Cancer-Linked Chemicals in U.S. Consumer Products

A new peer-reviewed study published in the journal Environmental Health Perspectives indicates that hundreds of potential breast carcinogens are widespread in U.S. consumer goods, food, drinking water, pesticides, drugs, and building materials. The research, led by Jennifer Kay of the Silent Spring Institute, found that exposure to these chemicals is ubiquitous, yet current biomonitoring efforts fail to adequately measure human exposure or assess risks from combined exposures. Chemicals derived from fossil fuels, particularly those used in plastics, account for significant production volumes and environmental releases of these potential carcinogens. Bisphenols and phthalates, commonly found in plastics, are highlighted for their ability to damage DNA, trigger cell division, and increase breast cancer risk. In 2019, over 5 billion pounds of potential breast carcinogens, including bisphenol A and chemicals known to cause mammary tumors in rodents like styrene, benzene, and vinyl chloride, were produced by ma...

Oncogenomics Revolutionizes Cancer Treatment Through Personalized Medicine

Oncogenomics Revolutionizes Cancer Treatment Through Personalized Medicine

Oncogenomics, a specialized field within personalized medicine, is transforming cancer treatment by focusing on the genomic analysis of tumors. This approach allows for the tailoring of medication regimens and therapies based on an individual's unique genetic profile. By understanding the specific genetic mutations associated with a patient's cancer, clinicians can develop more effective and targeted treatments. This method is a direct evolution from the Human Genome Project, which, completed in 2003, provided the foundational knowledge for advanced genetic testing. Oncogenomics is now a critical component in identifying metabolic programs linked to drug sensitivity, such as oxaliplatin in gastric cancer, offering valuable prognostic information and improving patient outcomes through sophisticated molecular analysis.

Genetic Mutation T790M Increases Lung Cancer Risk Significantly, Study Finds

Genetic Mutation T790M Increases Lung Cancer Risk Significantly, Study Finds

A new study has identified a rare inherited germline mutation, T790M, in the epidermal growth factor receptor (EGFR) gene that substantially increases the risk of lung cancer. Researchers, including Dr. Pasi Jänne of Dana-Farber Cancer Institute, analyzed 23andMe genotyping data from 3.37 million individuals and found this mutation in approximately one in 15,850 people. The study indicates that non-smokers with the T790M mutation face a 62 times higher risk of developing lung cancer, while smokers with the mutation are 25 times more likely to develop the disease. This finding highlights a significant genetic component to lung cancer risk, independent of tobacco exposure, which is traditionally considered the primary risk factor. The T790M mutation is believed to have originated in Southern Appalachian populations in the U.S. about 200 to 225 years ago. EGFR mutation-positive lung cancer accounts for 10% to 15% of lung cancers in the U.S., with a higher incidence in Asian populations.

AACR and Partners Advance Cancer Care in Ukraine Amid War Challenges

AACR and Partners Advance Cancer Care in Ukraine Amid War Challenges

The American Association for Cancer Research (AACR), in partnership with the Maria Skłodowska-Curie National Research Institute of Oncology (MSCI) in Poland and the Global Medical Knowledge Alliance (GMKA) Ukraine, is actively working to create new opportunities for cancer care in Ukraine despite the ongoing war. Clinicians and researchers, including Iryna Dudchenko, MD, PhD, from Sumy State University, are facing significant challenges such as constant air-raid alerts and logistical hurdles, leading to later diagnoses of malignancies. An 'AACR on Campus Poland/Ukraine' event in Warsaw brought together around 100 professionals to discuss early cancer detection, improving patient quality of life, and translating research into clinical care. Ukrainian researchers, like Anna Karavska, MD, are also studying the war's impact on oncology services and advocating for clinical trials to provide access to new therapies and adhere to global standards.

Ovarian Cancer Lacks Early Detection Test, Leading to Late-Stage Diagnoses

Ovarian Cancer Lacks Early Detection Test, Leading to Late-Stage Diagnoses

Ovarian cancer, the second most common gynecologic cancer in the U.S., has the highest death rate among all gynecologic cancers and is one of the leading causes of cancer deaths among women, trailing only lung and breast cancer. A significant challenge in combating this disease is the absence of an early detection test. Consequently, women are often diagnosed at advanced stages, which severely impacts treatment outcomes. Despite recent improvements in treatment and increased awareness leading to a slight drop in the death rate, experts emphasize that much more work is needed to address this critical diagnostic gap. Megan Neubauer, executive director of the Michigan Ovarian Cancer Alliance, highlighted the importance of understanding the disease and ongoing efforts to improve outcomes.

Study Links Residential Industrial Pollutant Exposure to Increased Breast Cancer Risk in Los Angeles

Study Links Residential Industrial Pollutant Exposure to Increased Breast Cancer Risk in Los Angeles

A recent study has found that residential exposure to certain industrial pollutants may increase the risk of developing breast cancer. Researchers analyzed data from over 53,000 women in Los Angeles County who are part of the California Multiethnic Cohort. By using data from the Toxics Release Inventory, the study estimated participants' exposure to 15 common industrial pollutants based on their home addresses and proximity to industrial release sites. The findings indicate that high levels of exposure to several pollutants were linked to a higher risk of breast cancer. For instance, breast cancer risk increased by 77% for 1,1,1-trichloroethane, 53% for tetrachloroethylene, and 17% for dichloromethane with each category increase in exposure level. Higher levels of diethanolamine and methyl ethyl ketone were also associated with elevated risk. Formaldehyde exposure was specifically linked to a 44% increase in hormone receptor-negative breast cancer risk.

University of Chicago Research Advocates for Combined Demand and Supply-Side Climate Policies for Global Emissions Reduction

University of Chicago Research Advocates for Combined Demand and Supply-Side Climate Policies for Global Emissions Reduction

Research from the University of Chicago's Energy Policy Institute (EPIC), led by Scholar Ryan Kellogg, emphasizes the necessity of a dual approach to climate policy, integrating both demand-side and supply-side strategies for effective and fair global emissions reduction. Published in a Brookings Papers on Economic Activity, the study highlights that carbon is a global pollutant, making a global perspective on emissions reductions paramount. Demand-side policies, such as emissions pricing and clean energy subsidies, aim to decrease the demand for fossil fuels. Conversely, supply-side policies, including extraction pricing or prohibitions on pipeline construction, focus on reducing the availability of fossil fuels. The research suggests that combining these approaches can mitigate 'leakage,' where domestic policies inadvertently increase emissions elsewhere by affecting global fossil fuel prices. For instance, a U.S. emissions tax might lower global fossil fuel prices, leading to increased consumption in ot...

OGT Unveils NGS Automation for SureSeq Workflows to Streamline Genomic Analysis

OGT Unveils NGS Automation for SureSeq Workflows to Streamline Genomic Analysis

OGT, a global provider of genomic research and diagnostic solutions, has introduced next-generation sequencing (NGS) automation capabilities for its SureSeq NGS portfolio. These new automated workflows are compatible with the Hamilton NGS STAR Line and aim to optimize laboratory resources and improve turnaround times. The automation is designed to remove labor-intensive manual steps in NGS library preparation, which is crucial for high-volume laboratories facing increasing sample volumes. Adrian Smith, CEO of OGT, stated that NGS automation is essential for maximizing NGS analysis in high-volume labs by increasing capacity, improving reproducibility, and allowing teams to focus on critical tasks. This advancement is part of OGT’s ongoing investment in its SureSeq solutions, which include a range of hematological malignancy-focused NGS panels like the recently launched SureSeq Myeloid MRD Plus NGS Panel. The goal is to provide clinical research labs with the throughput and confidence needed to extract compr...

Ladera Ranch Community Investigates Potential Environmental Links to Pediatric Cancer Cluster

Ladera Ranch Community Investigates Potential Environmental Links to Pediatric Cancer Cluster

Residents of Ladera Ranch, California, are actively investigating a perceived cluster of rare pediatric cancers, specifically Ewing sarcoma, within their community. This concern escalated following the deaths of young individuals, including 23-year-old Lilly Dalton and 17-year-old Brody Matteson, both diagnosed with rare cancers. While Ewing sarcoma is exceptionally rare, with only about 200 diagnoses in U.S. children and teens annually, residents have tallied seven cases in Ladera Ranch between 2007 and 2024, with at least one case per year since 2021. This number is considered higher than expected for a community of 26,000 people. The California Department of Public Health is currently reviewing whether there is an unusual number of cancer cases in the area, with results anticipated this fall. First Assistant U.S. Attorney Bilal Essayli has also requested the Environmental Protection Agency to assess potential environmental factors and any legal violations. Local institutions, including the community hom...

Medical Professionals Emphasize Importance of Travel History in Diagnosing Illnesses

Medical Professionals Emphasize Importance of Travel History in Diagnosing Illnesses

Medical professionals are highlighting the critical role of a patient's travel history in diagnosing illnesses, especially when symptoms are unexplained. Infections and environmental exposures are not uniformly distributed, meaning that a patient's recent travel, activities during travel, and the onset of symptoms can significantly influence the diagnostic process. This includes both international and domestic travel within the United States, as different regions can expose individuals to varying risks such as ticks, mosquitoes, fungi, or foodborne pathogens. The primary goal of inquiring about travel history is to ensure that no potentially relevant exposure is overlooked, allowing clinicians to consider a broader range of diagnoses beyond common explanations. The timing of travel is also crucial, as incubation periods for infections can range from days to months, meaning symptoms may appear long after a trip has concluded. Clinicians may ask about specific activities like hiking, camping, contact with an...

Precure Selects Helix as Multiomics Lab and AI Tools Provider for Mayo Clinic Initiative

Precure Selects Helix as Multiomics Lab and AI Tools Provider for Mayo Clinic Initiative

Precure, an initiative launched by the Mayo Clinic and founding partner Thermo Fisher Scientific, has selected Helix as its multiomics laboratory and AI tools provider. This collaboration aims to generate molecular data from approximately one million biospecimens to integrate molecular insights into routine clinical care at the Mayo Clinic and other health systems. Helix will supply advanced AI tools for genomics delivery in clinical settings and biomarker-driven research, alongside population-scale multiomic capabilities, including clinical whole genome sequencing (WGS) and research-grade proteome sequencing. The objective is to create new opportunities for disease prevention, diagnosis, and treatment by linking this data with longitudinal clinical information and high-performance computing infrastructure.